Advances in non-surgical treatment for pediatric patients with short bowel syndrome

References

• Goulet O, Ruemmele F, Lacaille F, et al. Irreversible intestinal failure. J Pediatr Gastroenterol Nutr. 2004;38(3):250–269.
   PubMed Web of Science ®Google Scholar
• Pironi L, Arends J, Baxter J, et al. ESPEN endorsed recommendations definition and classification of intestinal failure in adults. Clin Nutr. 2015;34(2):171–180.
   PubMed Web of Science ®Google Scholar
• Squires RH, Duggan C, Teitelbaum DH, et al. Natural history of pediatric intestinal failure: initial report from the pediatric intestinal failure consortium. J Pediatr. 2012;161(4):723,8.e2.
   PubMed Web of Science ®Google Scholar
• Amiot A, Messing B, Corcos O, et al. Determinants of home parenteral nutrition dependence and survival of 268 patients with non-malignant short bowel syndrome. Clin Nutr. 2013;32(3):368–374.
   PubMed Web of Science ®Google Scholar
• Wilmore DW. Factors correlating with a successful outcome following extensive intestinal resection in newborn infants. J Pediatr. 1972;80(1):88–95.
   PubMed Web of Science ®Google Scholar
• Stanger JD, Oliveira C, Blackmore C, et al. The impact of multi-disciplinary intestinal rehabilitation programs on the outcome of pediatric patients with intestinal failure: a systematic review and meta-analysis. J Pediatr Surg. 2013;48(5):983–992.
   PubMed Web of Science ®Google Scholar
• Raghu VK, Beaumont JL, Everly MJ, et al. Pediatric intestinal transplantation: analysis of the intestinal transplant registry. Pediatr Transplant. 2019;23(8):e13580.
   PubMed Web of Science ®Google Scholar
• Fullerton BS, Sparks EA, Hall AM, et al. Enteral autonomy, cirrhosis, and long term transplant-free survival in pediatric intestinal failure patients. J Pediatr Surg. 2016;51(1):96–100.
   PubMed Web of Science ®Google Scholar
• Torres C, Sudan D, Vanderhoof J, et al. Role of an intestinal rehabilitation program in the treatment of advanced intestinal failure. J Pediatr Gastroenterol Nutr. 2007;45(2):204–212.
   PubMed Web of Science ®Google Scholar
• Sigalet D, Boctor D, Robertson M, et al. Improved outcomes in paediatric intestinal failure with aggressive prevention of liver disease. Eur J Pediatr Surg. 2009;19(6):348–353.
   PubMed Web of Science ®Google Scholar
• Tappenden KA. Intestinal adaptation following resection. JPEN J Parenter Enteral Nutr. 2014;38(1 Suppl):23S–31S.
   PubMedGoogle Scholar
• Pironi L, Corcos O, Forbes A, et al. Intestinal failure in adults: recommendations from the ESPEN expert groups. Clin Nutr. 2018;37(6):1798–1809.
   PubMed Web of Science ®Google Scholar
• Castillo RO, Feng JJ, Stevenson DK, et al. Altered maturation of small intestinal function in the absence of intraluminal nutrients: rapid normalization with refeeding. Am J Clin Nutr. 1991;53(2):558–561.
   PubMed Web of Science ®Google Scholar
• Martin GR, Wallace LE, Hartmann B, et al. Nutrient-stimulated GLP-2 release and crypt cell proliferation in experimental short bowel syndrome. Am J Physiol Gastrointest Liver Physiol. 2005;288(3):G431–8.
   PubMed Web of Science ®Google Scholar
• Weaver LT, Austin S, Cole TJ. Small intestinal length: a factor essential for gut adaptation. Gut. 1991;32(11):1321–1323.
   PubMed Web of Science ®Google Scholar
• Struijs MC, Diamond IR, de Silva N, et al. Establishing norms for intestinal length in children. J Pediatr Surg. 2009;44(5):933–938.
   PubMed Web of Science ®Google Scholar
• Goulet O, Colomb-Jung V, Joly F. Role of the colon in short bowel syndrome and intestinal transplantation. J Pediatr Gastroenterol Nutr. 2009;48(Suppl 2):S66–S71.
   PubMedGoogle Scholar
• McLaughlin CM, Channabasappa N, Pace J, et al. Growth trajectory in children with short bowel syndrome during the first 2 years of life. J Pediatr Gastroenterol Nutr. 2018;66(3):484–488.
   PubMed Web of Science ®Google Scholar
• Pichler J, Chomtho S, Fewtrell M, et al. Growth and bone health in pediatric intestinal failure patients receiving long-term parenteral nutrition. Am J Clin Nutr. 2013;97(6):1260–1269.
   PubMed Web of Science ®Google Scholar
• Miyasaka EA, Brown PI, Kadoura S, et al. The adolescent child with short bowel syndrome: new onset of failure to thrive and need for increased nutritional supplementation. J Pediatr Surg. 2010;45(6):1280–1286.
   PubMed Web of Science ®Google Scholar
• Goulet O, Baglin-Gobet S, Talbotec C, et al. Outcome and long-term growth after extensive small bowel resection in the neonatal period: a survey of 87 children. Eur J Pediatr Surg. 2005;15(2):95–101.
   PubMed Web of Science ®Google Scholar
• Pereira-Fantini PM, Thomas SL, Taylor RG, et al. Colostrum supplementation restores insulin-like growth factor −1 levels and alters muscle morphology following massive small bowel resection. JPEN J Parenter Enteral Nutr. 2008;32(3):266–275.
   PubMed Web of Science ®Google Scholar
• Kulkarni S, Mercado V, Rios M, et al. Breast milk is better than formula milk in preventing parenteral nutrition-associated liver disease in infants receiving prolonged parenteral nutrition. J Pediatr Gastroenterol Nutr. 2013;57(3):383–388.
   PubMed Web of Science ®Google Scholar
• Vanderhoof JA, Grandjean CJ, Kaufman SS, et al. Effect of high percentage medium-chain triglyceride diet on mucosal adaptation following massive bowel resection in rats. JPEN J Parenter Enteral Nutr. 1984;8(6):685–689.
   PubMed Web of Science ®Google Scholar
• Bines JE, Taylor RG, Justice F, et al. Influence of diet complexity on intestinal adaptation following massive small bowel resection in a preclinical model. J Gastroenterol Hepatol. 2002;17(11):1170–1179.
   PubMed Web of Science ®Google Scholar
• Bines J, Francis D, Hill D. Reducing parenteral requirement in children with short bowel syndrome: impact of an amino acid-based complete infant formula. J Pediatr Gastroenterol Nutr. 1998;26(2):123–128.
   PubMed Web of Science ®Google Scholar
• Stamm DA, Hait E, Litman HJ, et al. High prevalence of eosinophilic gastrointestinal disease in children with intestinal failure. J Pediatr Gastroenterol Nutr. 2016;63(3):336–339.
   PubMed Web of Science ®Google Scholar
• Mazon A, Solera E, Alentado N, et al. Frequent IgE sensitization to latex, cow’s milk, and egg in children with short bowel syndrome. Pediatr Allergy Immunol. 2008;19(2):180–183.
   PubMed Web of Science ®Google Scholar
• Goulet O, Olieman J, Ksiazyk J, et al. Neonatal short bowel syndrome as a model of intestinal failure: physiological background for enteral feeding. Clin Nutr. 2013;32(2):162–171.
   PubMed Web of Science ®Google Scholar
• Kumpf VJ. Parenteral nutrition-associated liver disease in adult and pediatric patients. Nutr Clin Pract. 2006;21(3):279–290.
   PubMedGoogle Scholar
• Wales PW, Allen N, Worthington P, et al. A.S.P.E.N. clinical guidelines: support of pediatric patients with intestinal failure at risk of parenteral nutrition-associated liver disease. J Parenteral Enteral Nutr. 2014;38(5):538–557.
   PubMed Web of Science ®Google Scholar
• Nandivada P, Fell GL, Gura KM, et al. Lipid emulsions in the treatment and prevention of parenteral nutrition-associated liver disease in infants and children. Am J Clin Nutr. 2016;103(2):629S–34S.
   PubMed Web of Science ®Google Scholar
• Diamond IR, Grant RC, Pencharz PB, et al. Preventing the progression of intestinal failure-associated liver disease in infants using a composite lipid emulsion: a pilot randomized controlled trial of SMOFlipid. JPEN J Parenter Enteral Nutr. 2017;41(5):866–877.
   PubMed Web of Science ®Google Scholar
• Klek S, Chambrier C, Singer P, et al. Four-week parenteral nutrition using a third generation lipid emulsion (SMOFlipid)–a double-blind, randomised, multicentre study in adults. Clin Nutr. 2013;32(2):224–231.
   PubMed Web of Science ®Google Scholar
• Yang CF, Duro D, Zurakowski D, et al. High prevalence of multiple micronutrient deficiencies in children with intestinal failure: a longitudinal study. J Pediatr. 2011;159(1):39,44.e1.
   Web of Science ®Google Scholar
• Ubesie AC, Kocoshis SA, Mezoff AG, et al. Multiple micronutrient deficiencies among patients with intestinal failure during and after transition to enteral nutrition. J Pediatr. 2013;163(6):1692–1696.
   PubMed Web of Science ®Google Scholar
• Domellöf M, Szitanyi P, Simchowitz V, et al. ESPGHAN/ESPEN/ESPR/CSPEN guidelines on pediatric parenteral nutrition: iron and trace minerals. Clin Nutr. 2018;37(6):2354–2359.
   PubMed Web of Science ®Google Scholar
• Neelis E, Olieman J, Rizopoulos D, et al. Growth, body composition, and micronutrient abnormalities during and after weaning off home parenteral nutrition. J Pediatr Gastroenterol Nutr. 2018;67(5):e95–e100.
   PubMed Web of Science ®Google Scholar
• Namjoshi SS, Muradian S, Bechtold H, et al. Nutrition deficiencies in children with intestinal failure receiving chronic parenteral nutrition. JPEN J Parenter Enteral Nutr. 2018;42(2):427–435.
   PubMed Web of Science ®Google Scholar
• Lee D, Barsky D, Hughes R, et al. Evaluation of the safety of iron dextran with parenteral nutrition in the paediatric inpatient setting. Nutr Diet. 2017;74(5):471–475.
   PubMed Web of Science ®Google Scholar
• Laass MW, Straub S, Chainey S, et al. Effectiveness and safety of ferric carboxymaltose treatment in children and adolescents with inflammatory bowel disease and other gastrointestinal diseases. BMC Gastroenterol. 2014;14:184.
   PubMed Web of Science ®Google Scholar
• Rognoni C, Venturini S, Meregaglia M, et al. Efficacy and safety of ferric carboxymaltose and other formulations in iron-deficient patients: a systematic review and network meta-analysis of randomised controlled trials. Clin Drug Investig. 2016;36(3):177–194.
   PubMed Web of Science ®Google Scholar
• Jeppesen PB, Høy CE, Mortensen PB. Deficiencies of essential fatty acids, vitamin A and E and changes in plasma lipoproteins in patients with reduced fat absorption or intestinal failure. Eur J Clin Nutr. 2000;54(8):632–642.
   PubMed Web of Science ®Google Scholar
• Bronsky J, Campoy C, Braegger C. ESPGHAN/ESPEN/ESPR/CSPEN guidelines on pediatric parenteral nutrition: vitamins. Clin Nutr. 2018;37(6):2366–2378.
   PubMed Web of Science ®Google Scholar
• Braga CBM, Vannucchi H, Freire CMM, et al. Serum vitamins in adult patients with short bowel syndrome receiving intermittent parenteral nutrition. JPEN J Parenter Enteral Nutr. 2011;35(4):493–498.
   PubMed Web of Science ®Google Scholar
• Holick MF. Vitamin D deficiency. N Engl J Med (Online). 2007;357(3):266–281.
   PubMed Web of Science ®Google Scholar
• Ubesie AC, Heubi JE, Kocoshis SA, et al. Vitamin D deficiency and low bone mineral density in pediatric and young adult intestinal failure. J Pediatr Gastroenterol Nutr. 2013;57(3):372–376.
   PubMed Web of Science ®Google Scholar
• Nygaard L, Skallerup A, Olesen S, et al. Osteoporosis in patients with intestinal insufficiency and intestinal failure: prevalence and clinical risk factors. Clin Nutr. 2018;37(5):1654–1660.
   PubMed Web of Science ®Google Scholar
• Henry HL, Bouillon R, Norman AW, et al. 14th vitamin D workshop consensus on vitamin D nutritional guidelines. J Steroid Biochem Mol Biol. 2010;121(1–2):4–6.
   PubMed Web of Science ®Google Scholar
• Fell GL, Anez-Bustillos L, Dao DT, et al. Alpha-tocopherol in intravenous lipid emulsions imparts hepatic protection in a murine model of hepatosteatosis induced by the enteral administration of a parenteral nutrition solution. PLoS One. 2019;14(7):e0217155.
   PubMed Web of Science ®Google Scholar
• Zemrani B, Bines JE. Monitoring of long-term parenteral nutrition in children with intestinal failure. JGH Open. 2019;3(2):163–172.
   PubMed Web of Science ®Google Scholar
• Shearer MJ. Vitamin K in parenteral nutrition. Gastroenterology. 2009;137(5 Suppl):S105–18.
   PubMed Web of Science ®Google Scholar
• Krzyzanowska P, Ksiazyk J, Kocielinska-Klos M, et al. Vitamin K status in patients with short bowel syndrome. Clin Nutr. 2012;31(6):1015–1017.
   PubMed Web of Science ®Google Scholar
• Staun M, Pironi L, Bozzetti F, et al. ESPEN guidelines on parenteral nutrition: home parenteral nutrition (HPN) in adult patients. Clin Nutr. 2009;28(4):467–479.
   PubMed Web of Science ®Google Scholar
• Gunnar R, Lumia M, Pakarinen M, et al. Children with intestinal failure undergoing intestinal rehabilitation are at risk for essential fatty acid deficiency. JPEN J Parenter Enteral Nutr. 2018;42(7):1203–1210.
   PubMed Web of Science ®Google Scholar
• Stabler SP. Vitamin B12 deficiency. N Engl J Med. 2013;368(21):2041–2042.
   PubMedGoogle Scholar
• Jimenez L, Stamm DA, Depaula B, et al. Is serum methylmalonic acid a reliable biomarker of vitamin B12 status in children with short bowel syndrome: a case series. J Pediatr. 2018;192:259–261.
   PubMed Web of Science ®Google Scholar
• Ikomi C, Cole CR, Vale E, et al. Hypothyroidism and iodine deficiency in children on chronic parenteral nutrition. Pediatrics. 2018;141(4):e20173046.
   PubMed Web of Science ®Google Scholar
• Chaiyakunapruk N, Veenstra DL, Lipsky BA, et al. Chlorhexidine compared with povidone-iodine solution for vascular catheter-site care: a meta-analysis. Ann Intern Med. 2002;136(11):792–801.
   PubMed Web of Science ®Google Scholar
• Pironi L, Guidetti M, Agostini F. Iodine status in intestinal failure in adults. Curr Opin Clin Nutr Metab Care. 2015;18(6):582–587.
   PubMed Web of Science ®Google Scholar
• Burghardt KM, Wales PW, de Silva N, et al. Pediatric intestinal transplant listing criteria – A call for a change in the new era of intestinal failure outcomes. Am J Transplant. 2019;15(6):1674–1681.
   Google Scholar
• Wall C, Moore J, Thachil J. Catheter-related thrombosis: a practical approach. J Intensive Care Soc. 2016;17(2):160–167.
   PubMedGoogle Scholar
• Baskin KM, Mermel LA, Saad TF, et al. Evidence-based strategies and recommendations for preservation of central venous access in children. JPEN J Parenter Enteral Nutr. 2019;43:591–614.
   PubMed Web of Science ®Google Scholar
• Smith R, Jones S, Newall F. Six weeks versus 3 months of anticoagulant treatment for pediatric central venous catheter-related venous thromboembolism. J Pediatr Hematol Oncol. 2017;39(7):518–523.
   PubMed Web of Science ®Google Scholar
• Kearon C, Kahn SR, Agnelli G, et al. Antithrombotic therapy for venous thromboembolic disease: American college of chest physicians evidence-based clinical practice guidelines (8th edition). Chest. 2008;133(6 Suppl):454S–545S.
   PubMed Web of Science ®Google Scholar
• Pierret ACS, Wilkinson JT, Zilbauer M, et al. Clinical outcomes in pediatric intestinal failure: a meta-analysis and meta-regression. Am J Clin Nutr. 2019;110:430–436.
   PubMed Web of Science ®Google Scholar
• Szydlowski EG, Rudolph JA, Vitale MA, et al. Bloodstream infections in patients with intestinal failure presenting to a pediatric emergency department with fever and a central line. Pediatr Emerg Care. 2017;33(12):e140–5.
   PubMed Web of Science ®Google Scholar
• Bond A, Chadwick P, Smith TR, et al. Diagnosis and management of catheter-related bloodstream infections in patients on home parenteral nutrition. Frontline Gastroenterol. 2020;11(1):48–54.
   PubMed Web of Science ®Google Scholar
• Raphael BP, Fournier G, McLaughlin SR, et al. Antibiotic susceptibility and therapy in central line infections in pediatric home parenteral nutrition patients. J Pediatr Gastroenterol Nutr. 2020;70(1):59–63.
   PubMed Web of Science ®Google Scholar
• Robinson JL, Casey LM, Huynh HQ, et al. Prospective cohort study of the outcome of and risk factors for intravascular catheter-related bloodstream infections in children with intestinal failure. JPEN J Parenter Enteral Nutr. 2014;38(5):625–630.
   PubMed Web of Science ®Google Scholar
• Rahhal R, Abu-El-Haija MA, Fei L, et al. Systematic review and meta-analysis of the utilization of ethanol locks in pediatric patients with intestinal failure. JPEN J Parenter Enteral Nutr. 2018;42(4):690–701.
   PubMed Web of Science ®Google Scholar
• Crnich CJ, Halfmann JA, Crone WC, et al. The effects of prolonged ethanol exposure on the mechanical properties of polyurethane and silicone catheters used for intravascular access. Infect Control Hosp Epidemiol. 2005;26(8):708–714.
   PubMed Web of Science ®Google Scholar
• Lambe C, Poisson C, Talbotec C, et al. Strategies to reduce catheter-related bloodstream infections in pediatric patients receiving home parenteral nutrition: the efficacy of taurolidine-citrate prophylactic-locking. JPEN J Parenter Enteral Nutr. 2018;42(6):1017–1025.
   PubMed Web of Science ®Google Scholar
• Kanaa M, Wright MJ, Akbani H, et al. Cathasept line lock and microbial colonization of tunneled hemodialysis catheters: a multicenter randomized controlled trial. Am J Kidney Dis. 2015;66(6):1015–1023.
   PubMed Web of Science ®Google Scholar
• Olthof ED, Versleijen MW, Huisman-de Waal G, et al. Taurolidine lock is superior to heparin lock in the prevention of catheter related bloodstream infections and occlusions. PLoS One. 2014;9(11):e111216.
   PubMed Web of Science ®Google Scholar
• Liu Y, Zhang AQ, Cao L, et al. Taurolidine lock solutions for the prevention of catheter-related bloodstream infections: a systematic review and meta-analysis of randomized controlled trials. PLoS One. 2013;8(11):e79417.
   PubMed Web of Science ®Google Scholar
• Kaptanoglu L, Kucuk HF, Colak E, et al. The effect of taurolidine on experimental thrombus formation. Eur J Pharmacol. 2008;578(2–3):238–241.
   PubMed Web of Science ®Google Scholar
• Rodriguez D, Ryan P, Toro Monjaraz EM, et al. Small intestinal bacterial overgrowth in children: a state-of-the-art review. Front Pediatr. 2019;7(1):1–19.
   PubMedGoogle Scholar
• Rao SSC, Bhagatwala J. Small intestinal bacterial overgrowth: clinical features and therapeutic management. Clin Transl Gastroenterol. 2019;10(10):e00078.
   PubMed Web of Science ®Google Scholar
• Malik BA, Xie YY, Wine E, et al. Diagnosis and pharmacological management of small intestinal bacterial overgrowth in children with intestinal failure. Can J Gastroenterol. 2011;25(1):41–45.
   PubMed Web of Science ®Google Scholar
• Dukowicz AC, Lacy BE, Levine GM. Small intestinal bacterial overgrowth: a comprehensive review. J Gastroenterol Hepatol. 2007;3(2):112–122.
   Google Scholar
• Bohm M, Siwiec RM, Wo JM. Diagnosis and management of small intestinal bacterial overgrowth. Nutr clin pract. 2013;28(3):289–299.
   PubMed Web of Science ®Google Scholar
• Quigley EMM, Quera R. Small intestinal bacterial overgrowth: roles of antibiotics, prebiotics, and probiotics. Gastroenterology. 2006;130(2):S78–90.
   PubMed Web of Science ®Google Scholar
• Sieczkowska A, Landowski P, Kaminska B, et al. Small bowel bacterial overgrowth in children. J Pediatr Gastroenterol Nutr. 2016;62(2):196–207.
   PubMed Web of Science ®Google Scholar
• Lauritano EC, Gabrielli M, Scarpellini E, et al. Antibiotic therapy in small intestinal bacterial overgrowth: rifaximin versus metronidazole. Eur Rev Med Pharmacol Sci. 2009;13(2):111–116.
   PubMed Web of Science ®Google Scholar
• Lexicomp online, pediatric and neonatal lexi-drugs online, hudson, ohio: wolters kluwer clinical drug information, inc [Internet]; 2013 [cited 2020 Feb 23]. Available from: http://www.crlonline.com/lco/action/home
   Google Scholar
• Zhong C, Qu C, Wang B, et al. Probiotics for preventing and treating small intestinal bacterial overgrowth: a meta-analysis and systematic review of current evidence. J Clin Gastroenterol. 2017;51(4):300–311.
   PubMed Web of Science ®Google Scholar
• Reddy VS, Patole SK, Rao S. Role of probiotics in short bowel syndrome in infants and children–a systematic review. Nutrients. 2013;5(3):679–699.
   PubMed Web of Science ®Google Scholar
• Kowlgi NG, Chhabra L. D-lactic acidosis: an underrecognized complication of short bowel syndrome. Gastroenterol Res Pract. 2015;2015:476215.
   PubMed Web of Science ®Google Scholar
• Ewaschuk JB, Naylor JM, Zello GA. D-lactate in human and ruminant metabolism. J Nutr. 2005;135:1619–1625.
   PubMed Web of Science ®Google Scholar
• Bass LM, Zimont J, Prozialeck J, et al. Intestinal anastomotic ulcers in children with short bowel syndrome and anemia detected by capsule endoscopy. J Pediatr Gastroenterol Nutr. 2015;61(2):215–219.
   PubMed Web of Science ®Google Scholar
• Fusaro F, Tambucci R, Romeo E, et al. Anastomotic ulcers in short bowel syndrome: new suggestions from a multidisciplinary approach. J Pediatr Surg. 2018;53(3):483–488.
   PubMed Web of Science ®Google Scholar
• Charbit-Henrion F, Chardot C, Ruemmele F, et al. Anastomotic ulcerations after intestinal resection in infancy. J Pediatr Gastroenterol Nutr. 2014;59(4):531–536.
   PubMed Web of Science ®Google Scholar
• Freeman JJ, Rabah R, Hirschl RB, et al. Anti-TNF-alpha treatment for post-anastomotic ulcers and inflammatory bowel disease with crohn’s-like pathologic changes following intestinal surgery in pediatric patients. Pediatr Surg Int. 2015;31(1):77–82.
   PubMed Web of Science ®Google Scholar
• Poddar U. Diagnostic and therapeutic approach to upper gastrointestinal bleeding. Paediatr Int Child Health. 2019;39(1):18–22.
   PubMed Web of Science ®Google Scholar
• Bechtold ML, McClave SA, Palmer LB, et al. The pharmacologic treatment of short bowel syndrome: new tricks and novel agents. Curr Gastroenterol Rep. 2014;16(7):392.
   PubMedGoogle Scholar
• MacLaren R, Reynolds PM, Allen RR. Histamine-2 receptor antagonists vs proton pump inhibitors on gastrointestinal tract hemorrhage and infectious complications in the intensive care unit. JAMA Intern Med. 2014;174(4):564–574.
   PubMed Web of Science ®Google Scholar
• Levy EI, Hoang DM, Vandenplas Y. The effects of proton pump inhibitors on the microbiome in young children. Acta Paediatrica (Oslo). 2020:1–8.
   PubMed Web of Science ®Google Scholar
• Carroll RE, Benedetti E, Schowalter JP, et al. Management and complications of short bowel syndrome: an updated review. Curr Gastroenterol Rep. 2016;18(7):40.
   PubMedGoogle Scholar
• Kumpf VJ. Pharmacologic management of diarrhea in patients with short bowel syndrome. JPEN J Parenter Enteral Nutr. 2020;38(1):38S–44S.
   Google Scholar
• Matarese LE. Nutrition and fluid optimization for patients with short bowel syndrome. JPEN J Parenter Enteral Nutr. 2013;37(2):161–170.
   PubMed Web of Science ®Google Scholar
• Sundaram A, Koutkia P, Apovian CM. Nutritional management of short bowel syndrome in adults. J Clin Gastroenterol. 2002;34(3):207–220.
   PubMed Web of Science ®Google Scholar
• Olm M, Gonzalez FJ, Garcia-Valdecasas J, et al. Necrotising colitis with perforation in diarrhoic patients treated with loperamide. Eur J Clin Pharmacol. 1991;40(4):415–416.
   PubMed Web of Science ®Google Scholar
• Cooper JC, Williams NS, King RF, et al. Effects of a long-acting somatostatin analogue in patients with severe ileostomy diarrhoea. Br J Surg. 1986;73(2):128–131.
   PubMed Web of Science ®Google Scholar
• Ladefoged K, Christensen KC, Hegnhøj J, et al. Effect of a long acting somatostatin analogue SMS 201-995 on jejunostomy effluents in patients with severe short bowel syndrome. Gut. 1989;30(7):943–949.
   PubMed Web of Science ®Google Scholar
• Chaudhri O, Small C, Bloom S. Gastrointestinal hormones regulating appetite. Philos Trans R Soc Lond B Biol Sci. 2006;361(1471):1187–1209.
   PubMed Web of Science ®Google Scholar
• Pironi L, Arends J, Bozzetti F, et al. ESPEN guidelines on chronic intestinal failure in adults. Clin Nutr. 2016;35(2):247–307.
   PubMed Web of Science ®Google Scholar
• Wales PW, Nasr A, de Silva N, et al. Human growth hormone and glutamine for patients with short bowel syndrome. Cochrane Database Syst Rev. 2010;6:CD006321.
   Google Scholar
• Duggan C, Stark AR, Auestad N, et al. Glutamine supplementation in infants with gastrointestinal disease: a randomized, placebo-controlled pilot trial. Nutrition. 2004;20(9):752–756.
   PubMed Web of Science ®Google Scholar
• Wagner JV, Moe-Byrne T, Grover Z, et al. Glutamine supplementation for young infants with severe gastrointestinal disease. Cochrane Database Syst Rev. 2012;7:CD005947.
   Google Scholar
• Shehadeh N, Sukhotnik I, Shamir R. Gastrointestinal tract as a target organ for orally administered insulin. J Pediatr Gastroenterol Nutr. 2006;43(3):276–281.
   PubMed Web of Science ®Google Scholar
• Sukhotnik I, Shehadeh N, Shamir R, et al. Oral insulin enhances intestinal regrowth following massive small bowel resection in rat. Dig Dis Sci. 2005;50(12):2379–2385.
   PubMed Web of Science ®Google Scholar
• Shamir R, Kolacek S, Koletzko S, et al. Oral insulin supplementation in paediatric short bowel disease: a pilot observational study. J Pediatr Gastroenterol Nutr. 2009;49(1):108–111.
   PubMed Web of Science ®Google Scholar
• Nehra V, Camilleri M, Burton D, et al. An open trial of octreotide long-acting release in the management of short bowel syndrome. Am J Gastroenterol. 2001;96(5):1494–1498.
   PubMed Web of Science ®Google Scholar
• Byrne TA, Wilmore DW, Iyer K, et al. Growth hormone, glutamine, and an optimal diet reduces parenteral nutrition in patients with short bowel syndrome: a prospective, randomized, placebo-controlled, double-blind clinical trial. Ann Surg. 2005;242(5):655–661.
   PubMed Web of Science ®Google Scholar
• Drucker DJ. Gut adaptation and the glucagon-like peptides. Gut. 2002;50(3):428–435.
   PubMed Web of Science ®Google Scholar
• Xiao Q, Boushey RP, Drucker DJ, et al. Secretion of the intestinotropic hormone glucagon-like peptide 2 is differentially regulated by nutrients in humans. Gastroenterology. 1999;17(1):99–105.
   Google Scholar
• Jeppesen PB, Hartmann B, Thulesen J, et al. Elevated plasma glucagon-like peptide 1 and 2 concentrations in ileum resected short bowel patients with a preserved colon. Gut. 2000;47(3):370–376.
   PubMed Web of Science ®Google Scholar
• Jeppesen PB, Gilroy R, Pertkiewicz M, et al. Randomised placebo-controlled trial of teduglutide in reducing parenteral nutrition and/or intravenous fluid requirements in patients with short bowel syndrome. Gut. 2011;60(7):902–914.
   PubMed Web of Science ®Google Scholar
• Jeppesen PB, Sanguinetti EL, Buchman A, et al. Teduglutide (ALX-0600), a dipeptidyl peptidase IV resistant glucagon-like peptide 2 analogue, improves intestinal function in short bowel syndrome patients. Gut. 2005;54(9):1224–1231.
   PubMed Web of Science ®Google Scholar
• Carter BA, Cohran VC, Cole CR, et al. Outcomes from a 12-week, open-label, multicenter clinical trial of teduglutide in pediatric short bowel syndrome. J Pediatr. 2017;181(102):111.e5.
   Google Scholar
• Kocoshis SA, Merritt RJ, Hill S, et al. Safety and efficacy of teduglutide in pediatric patients with intestinal failure due to short bowel syndrome: a 24-week, phase III study. JPEN J Parenter Enteral Nutr. 2020;44(4):621–631.
   Web of Science ®Google Scholar
• Seidner DL, Fujioka K, Boullata JI, et al. Reduction of parenteral nutrition and hydration support and safety with long-term teduglutide treatment in patients with short bowel syndrome-associated intestinal failure: STEPS-3 study. Nutr Clin Pract. 2018;33(4):520–527.
   PubMed Web of Science ®Google Scholar
• Jeppesen PB. The long road to the development of effective therapies for the short gut syndrome: a personal perspective. Dig Dis Sci. 2019;64(10):2717–2735.
   PubMed Web of Science ®Google Scholar
• Hvistendahl MK, Naimi RM, Enevoldsen LH, et al. Effect of glepaglutide, a long-acting glucagon-like peptide-2 analog, on gastrointestinal transit time and motility in patients with short bowel syndrome: findings from a randomized trial. JPEN J Parenter Enteral Nutr. 2020. DOI:10.1002/jpen.1767
   Web of Science ®Google Scholar
• Slim GM, Lansing M, Wizzard P, et al. Novel long-acting GLP-2 analogue, FE 203799 (apraglutide), enhances adaptation and linear intestinal growth in a neonatal piglet model of short bowel syndrome with total resection of the ileum. JPEN J Parenter Enteral Nutr. 2019;43(7):891–898.
   PubMed Web of Science ®Google Scholar
• Hvistendahl M, Brandt CF, Tribler S, et al. Effect of liraglutide treatment on jejunostomy output in patients with short bowel syndrome: an open-label pilot study. JPEN J Parenter Enteral Nutr. 2018;42(1):112–121.
   PubMed Web of Science ®Google Scholar
• Wismann P, Pedersen SL, Hansen G, et al. Novel GLP-1/GLP-2 co-agonists display marked effects on gut volume and improves glycemic control in mice. Physiol Behav. 2018;192:72–81.
   PubMed Web of Science ®Google Scholar
• Madsen KB, Askov-Hansen C, Naimi RM, et al. Acute effects of continuous infusions of glucagon-like peptide (GLP)-1, GLP-2 and the combination (GLP-1+GLP-2) on intestinal absorption in short bowel syndrome (SBS) patients. A placebo-controlled study. Regul Pept. 2013;184:30–39.
   PubMed Web of Science ®Google Scholar